Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Intracranial Aneurysm | 54 | 2024 | 1276 | 6.210 |
Why?
|
Embolization, Therapeutic | 46 | 2024 | 1413 | 5.460 |
Why?
|
Endovascular Procedures | 42 | 2024 | 2165 | 2.980 |
Why?
|
Aneurysm, Ruptured | 16 | 2023 | 460 | 2.110 |
Why?
|
Thrombectomy | 24 | 2024 | 708 | 2.080 |
Why?
|
Cerebral Revascularization | 5 | 2022 | 249 | 1.980 |
Why?
|
Intracranial Arteriovenous Malformations | 9 | 2022 | 367 | 1.980 |
Why?
|
Brain Ischemia | 21 | 2024 | 3127 | 1.600 |
Why?
|
Subarachnoid Hemorrhage | 14 | 2023 | 1032 | 1.220 |
Why?
|
Central Nervous System Vascular Malformations | 4 | 2021 | 140 | 1.080 |
Why?
|
Cerebral Angiography | 19 | 2022 | 1274 | 1.060 |
Why?
|
Stents | 21 | 2024 | 3314 | 1.050 |
Why?
|
Arteriovenous Fistula | 4 | 2022 | 314 | 1.020 |
Why?
|
Stroke | 25 | 2024 | 9962 | 1.010 |
Why?
|
Intracranial Arteriosclerosis | 3 | 2020 | 137 | 0.980 |
Why?
|
Hematoma, Subdural, Chronic | 2 | 2023 | 92 | 0.910 |
Why?
|
Microsurgery | 6 | 2020 | 796 | 0.820 |
Why?
|
Carotid-Cavernous Sinus Fistula | 1 | 2022 | 37 | 0.810 |
Why?
|
Cavernous Sinus | 1 | 2022 | 123 | 0.770 |
Why?
|
Arterial Occlusive Diseases | 4 | 2022 | 752 | 0.750 |
Why?
|
Carotid Artery, Internal | 5 | 2020 | 438 | 0.740 |
Why?
|
Temporal Arteries | 3 | 2020 | 148 | 0.720 |
Why?
|
Treatment Outcome | 72 | 2024 | 65017 | 0.710 |
Why?
|
Blood Vessel Prosthesis | 4 | 2024 | 956 | 0.690 |
Why?
|
Basilar Artery | 3 | 2022 | 205 | 0.690 |
Why?
|
Neurosurgical Procedures | 8 | 2023 | 2056 | 0.630 |
Why?
|
Radiosurgery | 4 | 2018 | 1343 | 0.620 |
Why?
|
Intracranial Hemorrhages | 7 | 2023 | 844 | 0.620 |
Why?
|
Transverse Sinuses | 1 | 2018 | 25 | 0.600 |
Why?
|
Aneurysm, False | 3 | 2017 | 257 | 0.600 |
Why?
|
Angioplasty | 1 | 2020 | 361 | 0.580 |
Why?
|
Hemangioma, Cavernous, Central Nervous System | 1 | 2018 | 56 | 0.580 |
Why?
|
Saphenous Vein | 1 | 2020 | 537 | 0.560 |
Why?
|
Retrospective Studies | 68 | 2024 | 80372 | 0.540 |
Why?
|
Suction | 1 | 2017 | 263 | 0.520 |
Why?
|
Vertebrobasilar Insufficiency | 3 | 2021 | 112 | 0.500 |
Why?
|
Ossification of Posterior Longitudinal Ligament | 2 | 2011 | 18 | 0.470 |
Why?
|
Head Injuries, Closed | 1 | 2014 | 133 | 0.430 |
Why?
|
Vertebral Artery | 4 | 2022 | 185 | 0.400 |
Why?
|
Longitudinal Ligaments | 2 | 2011 | 25 | 0.400 |
Why?
|
Vascular Surgical Procedures | 2 | 2018 | 1475 | 0.400 |
Why?
|
Middle Aged | 73 | 2024 | 220352 | 0.390 |
Why?
|
Neurocytoma | 1 | 2011 | 29 | 0.390 |
Why?
|
Cerebral Ventricle Neoplasms | 1 | 2011 | 44 | 0.390 |
Why?
|
Cerebral Hemorrhage | 4 | 2022 | 2660 | 0.390 |
Why?
|
Thromboembolism | 4 | 2024 | 1017 | 0.380 |
Why?
|
Chondroblastoma | 1 | 2011 | 48 | 0.370 |
Why?
|
Preoperative Care | 1 | 2020 | 2256 | 0.370 |
Why?
|
Laser Therapy | 1 | 2018 | 1089 | 0.370 |
Why?
|
Cerebrovascular Circulation | 8 | 2020 | 2733 | 0.370 |
Why?
|
Angiogenic Proteins | 1 | 2011 | 101 | 0.370 |
Why?
|
Humans | 132 | 2024 | 760621 | 0.370 |
Why?
|
Bone Cysts, Aneurysmal | 1 | 2011 | 70 | 0.360 |
Why?
|
Vein of Galen Malformations | 2 | 2023 | 58 | 0.360 |
Why?
|
Craniotomy | 4 | 2023 | 741 | 0.360 |
Why?
|
Tissue Donors | 1 | 2020 | 2313 | 0.360 |
Why?
|
Growth Hormone-Secreting Pituitary Adenoma | 1 | 2010 | 49 | 0.360 |
Why?
|
Cerebrovascular Disorders | 1 | 2017 | 1501 | 0.350 |
Why?
|
Aged | 56 | 2024 | 169152 | 0.340 |
Why?
|
Male | 79 | 2024 | 359744 | 0.340 |
Why?
|
Thrombospondin 1 | 1 | 2011 | 257 | 0.330 |
Why?
|
Propensity Score | 4 | 2024 | 1928 | 0.310 |
Why?
|
Vasospasm, Intracranial | 3 | 2015 | 215 | 0.300 |
Why?
|
Platelet Aggregation Inhibitors | 5 | 2024 | 3201 | 0.300 |
Why?
|
Acromegaly | 1 | 2010 | 306 | 0.290 |
Why?
|
Thrombolytic Therapy | 5 | 2024 | 2108 | 0.290 |
Why?
|
Female | 80 | 2024 | 391270 | 0.290 |
Why?
|
Spinal Cord Vascular Diseases | 1 | 2017 | 10 | 0.290 |
Why?
|
Reperfusion | 4 | 2021 | 271 | 0.260 |
Why?
|
Seizures | 3 | 2022 | 2917 | 0.250 |
Why?
|
Ventriculostomy | 2 | 2017 | 131 | 0.250 |
Why?
|
Meningeal Arteries | 2 | 2023 | 67 | 0.250 |
Why?
|
Postoperative Complications | 8 | 2024 | 15697 | 0.250 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2010 | 1791 | 0.250 |
Why?
|
Nervous System Diseases | 2 | 2016 | 1647 | 0.250 |
Why?
|
Recurrence | 6 | 2016 | 8482 | 0.240 |
Why?
|
Follow-Up Studies | 19 | 2023 | 39261 | 0.240 |
Why?
|
Brain Neoplasms | 2 | 2018 | 8986 | 0.220 |
Why?
|
Maxillofacial Injuries | 1 | 2023 | 32 | 0.220 |
Why?
|
Surgical Instruments | 2 | 2016 | 385 | 0.210 |
Why?
|
Evoked Potentials, Somatosensory | 2 | 2014 | 246 | 0.210 |
Why?
|
Off-Label Use | 1 | 2024 | 184 | 0.210 |
Why?
|
Endothelial Cells | 4 | 2023 | 3539 | 0.200 |
Why?
|
Platelet Function Tests | 1 | 2024 | 303 | 0.200 |
Why?
|
Orbital Fractures | 1 | 2023 | 109 | 0.200 |
Why?
|
Mucopolysaccharidosis II | 1 | 2021 | 26 | 0.200 |
Why?
|
Cerebral Infarction | 3 | 2022 | 982 | 0.200 |
Why?
|
Spinal Cord Neoplasms | 2 | 2014 | 264 | 0.200 |
Why?
|
Neoplasm Metastasis | 2 | 2011 | 4902 | 0.190 |
Why?
|
Middle Cerebral Artery | 2 | 2020 | 276 | 0.190 |
Why?
|
Adult | 39 | 2024 | 219994 | 0.190 |
Why?
|
Neovascularization, Pathologic | 2 | 2011 | 2640 | 0.190 |
Why?
|
Hemodynamics | 3 | 2020 | 4174 | 0.190 |
Why?
|
Magnetic Resonance Angiography | 5 | 2020 | 1431 | 0.190 |
Why?
|
Retreatment | 3 | 2021 | 600 | 0.190 |
Why?
|
Evoked Potentials, Motor | 2 | 2014 | 461 | 0.180 |
Why?
|
Carotid Artery, Internal, Dissection | 1 | 2020 | 42 | 0.180 |
Why?
|
Enbucrilate | 1 | 2020 | 30 | 0.180 |
Why?
|
Cerebral Cortex | 3 | 2015 | 5761 | 0.180 |
Why?
|
Transplantation, Heterotopic | 1 | 2020 | 174 | 0.170 |
Why?
|
Coma | 1 | 2024 | 487 | 0.170 |
Why?
|
Adenoma | 1 | 2010 | 2148 | 0.170 |
Why?
|
Aged, 80 and over | 19 | 2024 | 58995 | 0.170 |
Why?
|
Vascular System Injuries | 1 | 2023 | 247 | 0.170 |
Why?
|
Brain Mapping | 1 | 2015 | 6568 | 0.170 |
Why?
|
Hydrodynamics | 1 | 2020 | 167 | 0.170 |
Why?
|
Cohort Studies | 12 | 2024 | 41335 | 0.160 |
Why?
|
Perfusion Imaging | 1 | 2020 | 196 | 0.160 |
Why?
|
Intracranial Thrombosis | 1 | 2020 | 109 | 0.160 |
Why?
|
Bone Neoplasms | 1 | 2011 | 2532 | 0.160 |
Why?
|
Brain Infarction | 1 | 2020 | 292 | 0.160 |
Why?
|
Leukoencephalopathies | 1 | 2020 | 249 | 0.150 |
Why?
|
Monitoring, Intraoperative | 2 | 2014 | 942 | 0.150 |
Why?
|
Angiography, Digital Subtraction | 4 | 2021 | 334 | 0.140 |
Why?
|
Vascular Patency | 1 | 2020 | 901 | 0.140 |
Why?
|
Biometry | 1 | 2020 | 559 | 0.140 |
Why?
|
Anastomosis, Surgical | 1 | 2020 | 983 | 0.140 |
Why?
|
Foreign-Body Migration | 1 | 2018 | 218 | 0.130 |
Why?
|
Carotid Stenosis | 2 | 2020 | 878 | 0.130 |
Why?
|
Cadaver | 1 | 2020 | 1345 | 0.130 |
Why?
|
Head | 1 | 2022 | 922 | 0.130 |
Why?
|
Spinal Cord | 2 | 2014 | 1817 | 0.130 |
Why?
|
Ophthalmic Artery | 1 | 2016 | 58 | 0.130 |
Why?
|
Decompression, Surgical | 3 | 2021 | 604 | 0.130 |
Why?
|
Polyvinyls | 1 | 2016 | 154 | 0.130 |
Why?
|
Carotid Artery Diseases | 1 | 2022 | 883 | 0.130 |
Why?
|
Dimethyl Sulfoxide | 1 | 2016 | 252 | 0.130 |
Why?
|
Sinus Thrombosis, Intracranial | 1 | 2016 | 110 | 0.120 |
Why?
|
Central Nervous System Infections | 1 | 2015 | 61 | 0.120 |
Why?
|
Transplantation, Autologous | 1 | 2020 | 2116 | 0.120 |
Why?
|
Vascular Diseases | 1 | 2023 | 1182 | 0.120 |
Why?
|
Magnetic Resonance Imaging | 10 | 2022 | 36290 | 0.120 |
Why?
|
alpha-Macroglobulins | 1 | 2014 | 60 | 0.120 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2018 | 633 | 0.120 |
Why?
|
Apolipoproteins A | 1 | 2014 | 95 | 0.120 |
Why?
|
Cerebrospinal Fluid Shunts | 1 | 2015 | 195 | 0.120 |
Why?
|
Aneurysm, Infected | 1 | 2014 | 81 | 0.110 |
Why?
|
Neck | 1 | 2018 | 731 | 0.110 |
Why?
|
Intraoperative Period | 1 | 2015 | 516 | 0.110 |
Why?
|
Ribonuclease, Pancreatic | 1 | 2014 | 149 | 0.110 |
Why?
|
Multicenter Studies as Topic | 2 | 2021 | 1722 | 0.110 |
Why?
|
Decompressive Craniectomy | 1 | 2014 | 76 | 0.110 |
Why?
|
Phenotype | 1 | 2011 | 16546 | 0.110 |
Why?
|
Internship and Residency | 2 | 2023 | 5870 | 0.110 |
Why?
|
beta-Alanine | 1 | 2013 | 82 | 0.100 |
Why?
|
Hydrocephalus | 2 | 2017 | 763 | 0.100 |
Why?
|
Wounds, Gunshot | 1 | 2018 | 581 | 0.100 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2019 | 1728 | 0.100 |
Why?
|
Prospective Studies | 9 | 2022 | 54303 | 0.100 |
Why?
|
Metabolomics | 1 | 2021 | 1628 | 0.100 |
Why?
|
Aneurysm | 1 | 2015 | 337 | 0.100 |
Why?
|
Device Approval | 1 | 2013 | 165 | 0.100 |
Why?
|
Blood Vessel Prosthesis Implantation | 2 | 2024 | 1446 | 0.100 |
Why?
|
Anisotropy | 1 | 2015 | 1278 | 0.090 |
Why?
|
Moyamoya Disease | 1 | 2014 | 255 | 0.090 |
Why?
|
Disease Progression | 4 | 2018 | 13502 | 0.090 |
Why?
|
Tomography, X-Ray Computed | 7 | 2018 | 20509 | 0.090 |
Why?
|
Magnetoencephalography | 1 | 2015 | 634 | 0.090 |
Why?
|
Risk Factors | 10 | 2024 | 74359 | 0.090 |
Why?
|
Disease Management | 3 | 2016 | 2514 | 0.090 |
Why?
|
Antithrombins | 1 | 2013 | 313 | 0.090 |
Why?
|
Time Factors | 6 | 2021 | 40165 | 0.090 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2019 | 2053 | 0.090 |
Why?
|
Graft Occlusion, Vascular | 1 | 2013 | 560 | 0.080 |
Why?
|
Electric Stimulation | 1 | 2015 | 1735 | 0.080 |
Why?
|
Kaplan-Meier Estimate | 1 | 2020 | 6544 | 0.080 |
Why?
|
Drainage | 1 | 2015 | 1161 | 0.080 |
Why?
|
Ischemic Attack, Transient | 1 | 2014 | 901 | 0.080 |
Why?
|
Combined Modality Therapy | 3 | 2024 | 8552 | 0.080 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2011 | 507 | 0.080 |
Why?
|
Fibrinolytic Agents | 3 | 2024 | 2167 | 0.080 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 1 | 2009 | 305 | 0.080 |
Why?
|
Neural Tube Defects | 1 | 2010 | 254 | 0.080 |
Why?
|
Benzimidazoles | 1 | 2013 | 858 | 0.070 |
Why?
|
Young Adult | 9 | 2023 | 58741 | 0.070 |
Why?
|
Reoperation | 4 | 2023 | 4291 | 0.070 |
Why?
|
Heat-Shock Proteins | 1 | 2011 | 795 | 0.070 |
Why?
|
Neurosurgery | 1 | 2013 | 670 | 0.070 |
Why?
|
Smoking | 2 | 2020 | 9073 | 0.070 |
Why?
|
Temporal Bone | 1 | 2011 | 683 | 0.070 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2011 | 841 | 0.060 |
Why?
|
Human Growth Hormone | 1 | 2010 | 638 | 0.060 |
Why?
|
Comorbidity | 1 | 2020 | 10551 | 0.060 |
Why?
|
Imaging, Three-Dimensional | 2 | 2020 | 4048 | 0.060 |
Why?
|
Osteotomy | 1 | 2010 | 836 | 0.060 |
Why?
|
United States Food and Drug Administration | 1 | 2013 | 1677 | 0.060 |
Why?
|
Tissue Plasminogen Activator | 2 | 2021 | 1190 | 0.060 |
Why?
|
Severity of Illness Index | 3 | 2024 | 15840 | 0.060 |
Why?
|
Tumor Burden | 1 | 2010 | 1895 | 0.060 |
Why?
|
Diffusion Tensor Imaging | 1 | 2015 | 2385 | 0.060 |
Why?
|
p120 GTPase Activating Protein | 1 | 2023 | 36 | 0.060 |
Why?
|
Morbidity | 2 | 2020 | 1765 | 0.060 |
Why?
|
Athletic Injuries | 1 | 2014 | 1209 | 0.060 |
Why?
|
Temporal Lobe | 1 | 2011 | 1688 | 0.050 |
Why?
|
Telemedicine | 1 | 2021 | 3018 | 0.050 |
Why?
|
Cardiac Surgical Procedures | 1 | 2018 | 3620 | 0.050 |
Why?
|
Spine | 1 | 2010 | 1111 | 0.050 |
Why?
|
Hypertension | 2 | 2020 | 8594 | 0.050 |
Why?
|
Transforming Growth Factor beta | 1 | 2011 | 1959 | 0.050 |
Why?
|
Activin Receptors, Type II | 1 | 2023 | 124 | 0.050 |
Why?
|
Adolescent | 8 | 2023 | 87810 | 0.050 |
Why?
|
Physicians | 1 | 2021 | 4591 | 0.050 |
Why?
|
Computer Simulation | 1 | 2016 | 6218 | 0.050 |
Why?
|
Anterior Cerebral Artery | 1 | 2022 | 50 | 0.050 |
Why?
|
Patient Selection | 3 | 2022 | 4283 | 0.050 |
Why?
|
Pituitary Neoplasms | 1 | 2010 | 1313 | 0.050 |
Why?
|
Diabetes Mellitus | 1 | 2020 | 5889 | 0.050 |
Why?
|
Aspirin | 2 | 2024 | 3364 | 0.050 |
Why?
|
Angiography | 1 | 2017 | 1605 | 0.050 |
Why?
|
Databases, Factual | 3 | 2021 | 8035 | 0.050 |
Why?
|
Risk Assessment | 5 | 2024 | 24123 | 0.050 |
Why?
|
Mutation | 3 | 2023 | 29932 | 0.050 |
Why?
|
Learning Curve | 1 | 2022 | 231 | 0.050 |
Why?
|
GTPase-Activating Proteins | 1 | 2023 | 475 | 0.040 |
Why?
|
Predictive Value of Tests | 4 | 2020 | 15289 | 0.040 |
Why?
|
Orbit | 1 | 2023 | 446 | 0.040 |
Why?
|
Diffusion Magnetic Resonance Imaging | 2 | 2021 | 2782 | 0.040 |
Why?
|
Ephrins | 1 | 2018 | 28 | 0.040 |
Why?
|
Scalp | 1 | 2022 | 389 | 0.040 |
Why?
|
Receptor, EphB4 | 1 | 2018 | 39 | 0.040 |
Why?
|
Diagnosis, Differential | 1 | 2014 | 12965 | 0.040 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2015 | 8950 | 0.040 |
Why?
|
Positron-Emission Tomography | 1 | 2015 | 6465 | 0.040 |
Why?
|
American Heart Association | 1 | 2023 | 1081 | 0.040 |
Why?
|
Solubility | 1 | 2020 | 1088 | 0.040 |
Why?
|
Child, Preschool | 4 | 2015 | 42063 | 0.040 |
Why?
|
Neck Pain | 1 | 2019 | 186 | 0.040 |
Why?
|
Video Recording | 1 | 2023 | 955 | 0.040 |
Why?
|
Prosthesis Design | 1 | 2024 | 2135 | 0.040 |
Why?
|
Hospitals | 2 | 2021 | 3928 | 0.040 |
Why?
|
United States | 4 | 2023 | 72461 | 0.040 |
Why?
|
Porosity | 1 | 2018 | 349 | 0.040 |
Why?
|
Metalloendopeptidases | 1 | 2018 | 393 | 0.030 |
Why?
|
Penetrance | 1 | 2018 | 388 | 0.030 |
Why?
|
Balloon Occlusion | 1 | 2017 | 127 | 0.030 |
Why?
|
Carotid Artery, External | 1 | 2016 | 38 | 0.030 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2009 | 4353 | 0.030 |
Why?
|
Cross-Sectional Studies | 3 | 2023 | 25942 | 0.030 |
Why?
|
Electroencephalography | 2 | 2022 | 6189 | 0.030 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2009 | 3075 | 0.030 |
Why?
|
Stress, Mechanical | 1 | 2020 | 1666 | 0.030 |
Why?
|
Cells, Cultured | 1 | 2011 | 18957 | 0.030 |
Why?
|
Cell Proliferation | 1 | 2011 | 10446 | 0.030 |
Why?
|
Blood Flow Velocity | 1 | 2019 | 1377 | 0.030 |
Why?
|
Indocyanine Green | 1 | 2016 | 236 | 0.030 |
Why?
|
Child | 6 | 2023 | 79806 | 0.030 |
Why?
|
Mutation, Missense | 1 | 2023 | 2566 | 0.030 |
Why?
|
Decision Support Techniques | 1 | 2024 | 2001 | 0.030 |
Why?
|
Metabolome | 1 | 2021 | 982 | 0.030 |
Why?
|
Tomography Scanners, X-Ray Computed | 1 | 2015 | 172 | 0.030 |
Why?
|
Patient Transfer | 1 | 2021 | 779 | 0.030 |
Why?
|
Triage | 1 | 2021 | 987 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2022 | 2326 | 0.030 |
Why?
|
Selection Bias | 1 | 2015 | 358 | 0.030 |
Why?
|
Feasibility Studies | 1 | 2024 | 5201 | 0.030 |
Why?
|
Finite Element Analysis | 1 | 2015 | 428 | 0.030 |
Why?
|
Ultrasonography, Doppler, Transcranial | 1 | 2015 | 281 | 0.030 |
Why?
|
Cervical Vertebrae | 1 | 2019 | 978 | 0.030 |
Why?
|
Nonlinear Dynamics | 1 | 2015 | 494 | 0.030 |
Why?
|
False Negative Reactions | 1 | 2013 | 573 | 0.030 |
Why?
|
Information Dissemination | 1 | 2021 | 1131 | 0.030 |
Why?
|
Neurologic Examination | 1 | 2015 | 916 | 0.030 |
Why?
|
DNA-Binding Proteins | 1 | 2009 | 9585 | 0.020 |
Why?
|
Incidence | 2 | 2024 | 21392 | 0.020 |
Why?
|
Age Factors | 2 | 2021 | 18416 | 0.020 |
Why?
|
Endocarditis, Bacterial | 1 | 2015 | 445 | 0.020 |
Why?
|
Tomography, Emission-Computed | 1 | 2014 | 1121 | 0.020 |
Why?
|
California | 1 | 2015 | 1416 | 0.020 |
Why?
|
Education, Medical, Graduate | 1 | 2023 | 2363 | 0.020 |
Why?
|
Substance Abuse, Intravenous | 1 | 2015 | 530 | 0.020 |
Why?
|
Pedigree | 1 | 2018 | 4578 | 0.020 |
Why?
|
North America | 1 | 2014 | 1284 | 0.020 |
Why?
|
Sex Characteristics | 1 | 2021 | 2629 | 0.020 |
Why?
|
Intraoperative Complications | 1 | 2017 | 1186 | 0.020 |
Why?
|
Area Under Curve | 1 | 2015 | 1636 | 0.020 |
Why?
|
Cell Growth Processes | 1 | 2011 | 384 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2019 | 2717 | 0.020 |
Why?
|
Recovery of Function | 1 | 2020 | 2985 | 0.020 |
Why?
|
Fatal Outcome | 1 | 2014 | 1832 | 0.020 |
Why?
|
Transcription Factors | 1 | 2009 | 12103 | 0.020 |
Why?
|
Salvage Therapy | 1 | 2016 | 1268 | 0.020 |
Why?
|
Brain Edema | 1 | 2014 | 603 | 0.020 |
Why?
|
Curriculum | 1 | 2023 | 3718 | 0.020 |
Why?
|
Skull | 1 | 2014 | 815 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 1 | 2011 | 17790 | 0.020 |
Why?
|
Spinal Cord Compression | 1 | 2011 | 235 | 0.020 |
Why?
|
Electromyography | 1 | 2014 | 1388 | 0.020 |
Why?
|
Terminology as Topic | 1 | 2016 | 1535 | 0.020 |
Why?
|
Signal Transduction | 2 | 2023 | 23376 | 0.020 |
Why?
|
Equipment Design | 1 | 2016 | 3520 | 0.020 |
Why?
|
Acute Disease | 1 | 2018 | 7269 | 0.020 |
Why?
|
Membrane Glycoproteins | 1 | 2018 | 3707 | 0.020 |
Why?
|
Mice, Transgenic | 2 | 2011 | 9530 | 0.020 |
Why?
|
Clinical Competence | 1 | 2023 | 4783 | 0.020 |
Why?
|
ROC Curve | 1 | 2015 | 3568 | 0.020 |
Why?
|
Contrast Media | 1 | 2020 | 5305 | 0.020 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2009 | 608 | 0.020 |
Why?
|
Anticoagulants | 1 | 2021 | 4897 | 0.020 |
Why?
|
Registries | 1 | 2021 | 8469 | 0.020 |
Why?
|
Mice | 3 | 2023 | 81208 | 0.020 |
Why?
|
Heterozygote | 1 | 2011 | 2798 | 0.010 |
Why?
|
Cell Separation | 1 | 2009 | 1720 | 0.010 |
Why?
|
Radiography | 1 | 2014 | 6965 | 0.010 |
Why?
|
Animals | 4 | 2023 | 167963 | 0.010 |
Why?
|
Prevalence | 1 | 2020 | 15687 | 0.010 |
Why?
|
Lumbar Vertebrae | 1 | 2010 | 1868 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2009 | 3442 | 0.010 |
Why?
|
Diagnostic Imaging | 1 | 2013 | 3527 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2015 | 14495 | 0.010 |
Why?
|
Emergency Service, Hospital | 1 | 2018 | 7818 | 0.010 |
Why?
|
Cell Movement | 1 | 2011 | 5206 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2009 | 5870 | 0.010 |
Why?
|
Tumor Microenvironment | 1 | 2011 | 3844 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2011 | 14372 | 0.010 |
Why?
|
Apoptosis | 1 | 2011 | 9501 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2011 | 8056 | 0.010 |
Why?
|
Prognosis | 1 | 2015 | 29658 | 0.010 |
Why?
|
Cytokines | 1 | 2009 | 7343 | 0.010 |
Why?
|
Infant | 1 | 2016 | 36060 | 0.010 |
Why?
|
Atherosclerosis | 1 | 2009 | 3517 | 0.010 |
Why?
|
Models, Biological | 1 | 2009 | 9467 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2011 | 22023 | 0.010 |
Why?
|
Brain | 1 | 2015 | 26951 | 0.000 |
Why?
|